Is DocuSign Stock Undervalued?
Digital signature software business DocuSign (NASDAQ:DOCU) has been struggling over…
| Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
|---|---|---|---|---|---|---|
| 02/03/2026 | Q4 | $125.1M | -- | -- | $0.02 | -- |
| 11/04/2025 | Q3 | $193.1M | $193.5M | $0.18 | $0.02 | $0.16 |
| 08/06/2025 | Q2 | $161.5M | $158M | -$0.10 | -$0.01 | -$0.09 |
| 04/29/2025 | Q1 | $127.7M | $130.6M | -$0.12 | -$0.06 | -$0.05 |
| 02/04/2025 | Q4 | $95.6M | $101.1M | $0.08 | $0.02 | $0.06 |
| 11/05/2024 | Q3 | $167.8M | $160.5M | -$0.24 | $0.04 | -$0.29 |
| 07/30/2024 | Q2 | $129.4M | $127.6M | -$0.08 | -$0.05 | -$0.02 |
| 04/30/2024 | Q1 | $113.4M | $110.1M | -$0.13 | -$0.03 | -$0.10 |
| 02/06/2024 | Q4 | $99.7M | $98.6M | $0.04 | $0.04 | $0.00 |
| 11/01/2023 | Q3 | $170.2M | $171.7M | -$2.89 | $0.27 | -$3.16 |
| 08/01/2023 | Q2 | -- | $135.4M | $0.09 | -- | -- |
| 05/02/2023 | Q1 | -- | $119.1M | $0.16 | -- | -- |
| 02/07/2023 | Q4 | -- | $107M | $0.15 | -- | -- |
| 11/01/2022 | Q3 | -- | $184.9M | -$0.94 | -- | -- |
| 08/09/2022 | Q2 | -- | $154.1M | -$0.88 | -- | -- |
| 05/02/2022 | Q1 | -- | $114M | -$0.17 | -- | -- |
| 02/08/2022 | Q4 | -- | $101.9M | $0.23 | -- | -- |
| 11/01/2021 | Q3 | -- | $163.4M | $0.12 | -- | -- |
| 07/29/2021 | Q2 | -- | $115.1M | -$0.06 | -- | -- |
| 05/03/2021 | Q1 | -- | $46M | -$0.12 | -- | -- |
| 02/09/2021 | Q4 | -- | $38.6M | -$0.12 | -- | -- |
| 11/02/2020 | Q3 | -- | $70.9M | -$0.06 | -- | -- |
| 07/28/2020 | Q2 | -- | $17.8M | -$0.33 | -- | -- |
| 05/18/2020 | Q1 | -- | $154M | -$3.36 | -- | -- |
| 02/12/2020 | Q4 | -- | $172.1M | $0.06 | -- | -- |
| 11/05/2019 | Q3 | -- | $278.6M | -- | -- | -- |
| 07/24/2019 | Q2 | -- | $251.3M | $0.11 | -- | -- |
| 05/01/2019 | Q1 | -- | $237.3M | $0.11 | -- | -- |
| 02/06/2019 | Q4 | -- | $190.3M | $0.19 | -- | -- |
| 10/24/2018 | Q3 | -- | $295.1M | $0.16 | -- | -- |
| 07/25/2018 | Q2 | -- | $279.9M | -$0.35 | -- | -- |
| 04/25/2018 | Q1 | -- | $318.8M | -$0.38 | -- | -- |
| 02/07/2018 | Q4 | -- | $213.7M | -$0.18 | -- | -- |
| 10/25/2017 | Q3 | -- | $338.1M | -$0.12 | -- | -- |
| 08/04/2017 | Q2 | -- | $328.6M | -$0.05 | -- | -- |
| 05/15/2017 | Q1 | -- | $285.3M | $0.11 | -- | -- |
| 02/24/2017 | Q4 | -- | $182.3M | $0.01 | -- | -- |
| 09/30/2016 | Q3 | -- | $275.3M | -$0.03 | -- | -- |
| 06/30/2016 | Q2 | -- | $202.1M | -$1.18 | -- | -- |
| 03/31/2016 | Q1 | -- | $175.6M | $0.00 | -- | -- |
| 12/31/2015 | Q4 | -- | $108.6M | -$0.04 | -- | -- |
trivago NV reported $193.5M worth of top line sales in its most recent quarter.
trivago NV announced earnings per share of $0.18 which represents a beat of analyst forecast a $0.02 per share.
trivago NV reported $187.1M that represents $2.62 per share over the last quarter.
trivago NV's earnings are forecast to decrease from -$0.37 per share to $0.03 per share next year representing a decrease of -97.9%.
trivago NV's next earnings date is February 3, 2026.
Signup to receive the latest stock alerts
Digital signature software business DocuSign (NASDAQ:DOCU) has been struggling over…
Cybersecurity major SentinelOne (NYSE:S) has struggled over several years, delivering…
Chip and software maker Broadcom (NASDAQ:AVGO) has been among the…
Market Cap: $4.6T
P/E Ratio: 64x
Market Cap: $4T
P/E Ratio: 37x
Market Cap: $3.8T
P/E Ratio: 39x
Hut 8 Corp. [HUT] is up 0.65% over the past day.
Travere Therapeutics, Inc. [TVTX] is up 14.03% over the past day.
Structure Therapeutics, Inc. [GPCR] is down 2.36% over the past day.